Cargando…
Stopping clinical trials early for futility: retrospective analysis of several randomised clinical studies
BACKGROUND: Many clinical trials show no overall benefit. We examined futility analyses applied to trials with different effect sizes. METHODS: Ten randomised cancer trials were retrospectively analysed; target sample size reached in all. The hazard ratio indicated no overall benefit (n=5), or moder...
Autores principales: | Jitlal, M, Khan, I, Lee, S M, Hackshaw, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464764/ https://www.ncbi.nlm.nih.gov/pubmed/22878376 http://dx.doi.org/10.1038/bjc.2012.344 |
Ejemplares similares
-
Stopping clinical trials early for futility: retrospective analysis of several randomised clinical studies
por: Jitlal, Mark, et al.
Publicado: (2011) -
A systematic survey of randomised trials that stopped early for reasons of futility
por: Walter, S. D., et al.
Publicado: (2020) -
Futility stopping in non-inferiority trials
por: Su, Zheng, et al.
Publicado: (2018) -
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility
por: Kimani, Peter K, et al.
Publicado: (2013) -
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
por: Northover, J, et al.
Publicado: (2010)